As of 2024-12-12, the Intrinsic Value of BiVictriX Therapeutics PLC (BVX.L) is
-16.18 GBP. This BVX.L valuation is based on the model Peter Lynch Fair Value.
With the current market price of 10.00 GBP, the upside of BiVictriX Therapeutics PLC is
-261.83%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-16.18 GBP
Intrinsic Value
BVX.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-16.18 - -16.18 |
-16.18 |
-261.83% |
| DDM - Stable |
(19.81) - (45.92) |
(32.87) |
-428.7% |
| DDM - Multi |
(2.08) - (3.74) |
(2.67) |
-126.7% |
BVX.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
8.25 |
| Beta |
-0.57 |
| Outstanding shares (mil) |
0.83 |
| Enterprise Value (mil) |
6.77 |
| Market risk premium |
5.98% |
| Cost of Equity |
12.89% |
| Cost of Debt |
5.00% |
| WACC |
12.62% |